The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s nucleic acid-based gene therapy market report forecasts the nucleic acid-based gene therapy market size to grow to $1.06 Billion by 2027, with a CAGR (compound annual growth rate) of more than 9%.

Learn More On The Nucleic Acid Based Gene Therapy Market Report 2023 – https://www.thebusinessresearchcompany.com/report/nucleic-acid-based-gene-therapy-global-market-report

Nucleic Acid Based Gene Therapy Market Size Forecas
The global nucleic acid based gene therapy market is expected to grow from $0.68 billion in 2022 to $0.75 billion in 2023 at a compound annual growth rate (CAGR) of 9.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The nucleic acid based gene therapy market is expected to grow from $1.06 billion in 2027 at a CAGR of 9.2%.

North America held the largest nucleic acid based gene therapy market share.

Key Nucleic Acid Based Gene Therapy Market Driver ­– Rise In The Financial Support By The Government
For instance, in August 2022, National Institute of Health (NIH) announced investment of $34 million annually for upcoming 5 years to develop HIV treatment research. The government support for gene therapies will contribute to the growth of the market.

Request for A Sample Of The Global Nucleic Acid Based Gene Therapy Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2820&type=smp

Technological advancements have emerged as a key trend gaining popularity in the nucleic acid-based gene therapy market. Major companies operating in the nucleic acid-based gene therapy market are focused on innovating new technologies to sustain their position in the market. For instance, in September 2022, Turn Biotechnologies, a US-based biotechnology company and a developer of mRNA medicines, launched eTurna, a novel delivery platform designed specifically to enable nucleic acid therapeutics. eTurna is created for the upcoming field of precision medical technology. It enables the precise targeting and tailoring of a variety of payloads that require diverse delivery techniques to specific tissues and cells. The company will apply the technology to distribute mRNA drugs created on the exclusive ERATM (Epigenetic Reprogramming of Aging) platform.

Nucleic Acid Based Gene Therapy Market Segment
1) By Technology: Anti-Sence and Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers, Other Technologies
2) By Application: Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases
3) By End User: Hospitals And Clinics, Academic And Research Institutes

Nucleic Acid Based Gene Therapy Market Major Players and Strategies
Major players in the nucleic acid based gene therapy market are Celsion Corporation, Wave Life Sciences, Imugene, Caperna, Phylogica, Protagonist Therapeutics, Benitec Biopharma, EGEN, BioMedica, Transgene, and Copernicus Therapeutics.

The Nucleic Acid Based Gene Therapy Global Market Report 2023 covers regional data on nucleic acid based gene therapy market size, nucleic acid based gene therapy market trends and drivers, opportunities, strategies, and nucleic acid based gene therapy market competitor analysis. The countries covered in the nucleic acidbased gene therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Gene therapy is used for correcting defective genes that are responsible for disease development. Nucleic acid-based therapeutics are used to treat genetic disorders and diseases for which there exists no permanent cure, such as anaemia, sickle cell, cystic fibrosis, and thalassemia.

View More Reports Related To The Nucleic Acid Based Gene Therapy Market –
Gene Therapy Global Market Report 2023
Gene Editing Global Market Report 2023
Genetic Testing Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: